Novartis Deals in Cardio Again, Dropping $1.4B to Acquire Tourmaline
Novartis has been investing heavily in its cardiovascular pipeline this year, forging partnerships with Flagship startup ProFound Therapeutics and China’s Argo Biopharmaceutical, among others.
Novartis Deals in Cardio Again, Dropping $1.4B to Acquire Tourmaline Read More »
